Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets-Reference-Cited by-同舟云学术

Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets

Published:2011-11 Issue:49 Volume:29 Page:9265-9270
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Stittelaar Koert J.,Veldhuis Kroeze Edwin J.B.,Rudenko Larisa,Dhere Rajeev,Thirapakpoomanunt Sit,Kieny Marie Paule,Osterhaus Albert D.M.E.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference35 articles.

1. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus;Hancock;N Engl J Med,2009

2. Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine;MMWR (Morb Mortal Wkly Rep),2009

3. The 2009 A (H1N1) influenza virus pandemic: a review;Girard;Vaccine,2010

4. Hospitalized patients with novel influenza A, (H1N1) virus infection - California;MMWR (Morb Mortal Wkly Rep),2009

5. Seasonal influenza vaccine provides priming for A/H1N1 immunization;Del Giudice;Sci Transl Med,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of Pre-Existing Immunity to Influenza on Live-Attenuated Influenza Vaccine (LAIV) Immunogenicity;Vaccines;2020-11-16

2. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains;Vaccine;2018-11

3. Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains;Human Vaccines & Immunotherapeutics;2017-01-02

4. Evaluation of a candidate live attenuated influenza vaccine prepared in Changchun BCHT (China) for safety and efficacy in ferrets;Vaccine;2016-11

5. Development and approval of live attenuated influenza vaccines based on Russian master donor viruses: Process challenges and success stories;Vaccine;2016-10